Korea’s Hanmi Hopes U.S. Esomeprazole Launch Will Counter Disappointing China Results
As Hanmi gears up for a U.S. launch of its modified version of AstraZeneca’s Nexium, it is also expanding global R&D initiatives to differentiate itself.
As Hanmi gears up for a U.S. launch of its modified version of AstraZeneca’s Nexium, it is also expanding global R&D initiatives to differentiate itself.